H-Lys-Leu-Val-Phe-Phe-OH manufacturers
|
| | H-Lys-Leu-Val-Phe-Phe-OH Basic information |
| Product Name: | H-Lys-Leu-Val-Phe-Phe-OH | | Synonyms: | KLVFF;LYS-LEU-VAL-PHE-PHE;BETA-AMYLOID (16-20);AMYLOID BETA-PROTEIN (16-20);AMYLOID-BETA PROTEIN (16-20), HUMAN, MOUSE, RAT;β-Amyloid (16-20);AMyloid b-Protein (16-20);Amyloid beta-Protein (16-20) trifluoroacetate salt | | CAS: | 153247-40-6 | | MF: | C35H52N6O6 | | MW: | 652.82 | | EINECS: | | | Product Categories: | peptide | | Mol File: | 153247-40-6.mol |  |
| | H-Lys-Leu-Val-Phe-Phe-OH Chemical Properties |
| Boiling point | 981.7±65.0 °C(Predicted) | | density | 1.170±0.06 g/cm3(Predicted) | | storage temp. | -15°C | | form | Solid | | pka | 3.50±0.10(Predicted) | | color | White to off-white | | Sequence | H-Lys-Leu-Val-Phe-Phe-OH |
| | H-Lys-Leu-Val-Phe-Phe-OH Usage And Synthesis |
| Uses | β-Amyloid peptide(16-20) is a amino acid sequences (KLVFF) of Amyloid-β (Abeta). β-Amyloid peptide(16-20) is an effective inhibitor of Abeta fibril formation, with RG-/-GR-NH2 residues added at N- and C-terminal ends to aid solubility)[1]. | | References | [1] Austen BM, et al. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide. Biochemistry. 2008 Feb 19;47(7):1984-92. DOI:10.1021/bi701415b |
| | H-Lys-Leu-Val-Phe-Phe-OH Preparation Products And Raw materials |
|